Omnicell/OMCL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Omnicell

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

Ticker

OMCL

Sector

Healthcare

Trading on

NASDAQ

Industry

Software & Programming

CEO

Randall Lipps

Employees

3,650

Headquarters

Fort worth, United States

Omnicell Metrics

BasicAdvanced
$1.5B
Market cap
-
P/E ratio
-$0.46
EPS
0.83
Beta
-
Dividend rate
$1.5B
0.83244
$77.14
$25.69
470K
2.378
2.129
47.993
47.993
128.022
-0.93%
-1.81%
-1.15%
1.357
1.259
8.108
9.095
-13.02%
-13.04%
8.74%

What the Analysts think about Omnicell

Analyst Ratings

Majority rating from 9 analysts.
Hold

Omnicell Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-6.33% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$246M
-4.91%
Net income
-$16M
9.09%
Profit margin
-6.33%
14.67%

Omnicell Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 131.99%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.57
$0.62
$0.33
$0.03
-
Expected
$0.28
$0.47
$0.15
-$0.09
$0.14
Surprise
101.97%
33.13%
115.22%
-131.99%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Omnicell stock?

Omnicell (OMCL) has a market cap of $1.5B as of June 19, 2024.

What is the P/E ratio for Omnicell stock?

The price to earnings (P/E) ratio for Omnicell (OMCL) stock is 0 as of June 19, 2024.

Does Omnicell stock pay dividends?

No, Omnicell (OMCL) stock does not pay dividends to its shareholders as of June 19, 2024.

When is the next Omnicell dividend payment date?

Omnicell (OMCL) stock does not pay dividends to its shareholders.

What is the beta indicator for Omnicell?

Omnicell (OMCL) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Omnicell stock price target?

The target price for Omnicell (OMCL) stock is $34.33, which is NaN% below the current price of $. This is an average based on projections from 6 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Omnicell stock

Buy or sell Omnicell stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing